Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2024

Mar 5, 2024

31971_dirs_2024-03-05_47bc6cd9-c4c0-41c9-af10-a87559c93dde.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-03-01

Reporting Person: Berge Terence M (VP-Corporate Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-01 Options To Purchase Common Stock $79.95 A 8000 Acquired 2034-03-01 Common Stock (8000) Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period